Literature DB >> 3945448

Maternal smoking and infant respiratory distress syndrome.

E White, K K Shy, J R Daling, R D Guthrie.   

Abstract

The relationship between maternal smoking and infant respiratory distress syndrome (RDS) was investigated among 550 premature (36 weeks or less) births delivered at the University of Washington Hospital from 1977 to 1980. Forty-five percent of the mothers were smokers. To avoid bias due to the reduced birth weight of infants of smokers, infants of smokers and nonsmokers were compared within small gestational age categories (two-week intervals) and not by birth weight categories. Infants of mothers who smoked had a reduced incidence of RDS for their gestation compared with infants of nonsmokers. The probability of RDS (adjusted for gestational age and method of delivery) was 25% for the infants of smokers versus 38% for the infants of nonsmokers (odds ratio = 0.55, P = .005), equivalent to approximately a 1.5-week acceleration in lung maturity for infants of smokers. The smoking effect was not explained by demographic differences between smokers and nonsmokers, nor by differences in the incidence of pregnancy complications between the two groups. This study adds support to the theory that adverse pregnancy conditions may lead to an acceleration in pulmonary maturity to allow earlier extrauterine adaptation.

Entities:  

Mesh:

Year:  1986        PMID: 3945448

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Does smoking in pregnancy modify the impact of antenatal steroids on neonatal respiratory distress syndrome? Results of the Epipage study.

Authors:  A Burguet; M Kaminski; P Truffert; A Menget; L Marpeau; M Voyer; J C Roze; B Escande; G Cambonie; J M Hascoet; H Grandjean; G Breart; B Larroque
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.

Authors:  H M Bryson; R Whittington
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

3.  Mimicking maternal smoking and pharmacotherapy of preterm labor: fetal nicotine exposure enhances the effect of late gestational dexamethasone treatment on noradrenergic circuits.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2011-08-19       Impact factor: 4.077

4.  Effects of smoking in pregnancy on neonatal lung function.

Authors:  A D Milner; M J Marsh; D M Ingram; G F Fox; C Susiva
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

5.  Prenatal drug exposures sensitize noradrenergic circuits to subsequent disruption by chlorpyrifos.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2015-09-28       Impact factor: 4.221

6.  Respiratory Outcome of the Former Premature Infants.

Authors:  Raluca Daniela Bogdan; Lidia Rusu; Adrian Ioan Toma; Leonard Nastase
Journal:  J Med Life       Date:  2019 Oct-Dec

7.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

8.  Impact of Wildfire Smoke on Adverse Pregnancy Outcomes in Colorado, 2007-2015.

Authors:  Mona Abdo; Isabella Ward; Katelyn O'Dell; Bonne Ford; Jeffrey R Pierce; Emily V Fischer; James L Crooks
Journal:  Int J Environ Res Public Health       Date:  2019-10-02       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.